Oncogene overexpression and de novo drug-resistance in human prostate cancer cells
- 12 April 1994
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1226 (1) , 89-96
- https://doi.org/10.1016/0925-4439(94)90063-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Synergistic interactions of etoposide and interleukin-1α are not due to DNA damage in human melanoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Etoposide-induced DNA damage in human tumor cells: requirement for cellular activating factorsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Use of the polymerase chain reaction in the quantitation of MDR-1 gene expressionBiochemistry, 1990
- Resistance to multiple chemotherapeutic agents in human cancer cellsTrends in Pharmacological Sciences, 1988
- Common DNA binding site for Fos protein complexesand transcription factor AP-1Cell, 1988
- Expression ofrasOncogene p21 in Prostate CancerNew England Journal of Medicine, 1986
- Superinduction of c- fos by Nerve Growth Factor in the Presence of Peripherally Active BenzodiazepinesScience, 1985
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogeneCell, 1984